In a pair of studies, researchers report that natural and synthetic strains of amyloid beta (Aβ) peptides trigger distinct patterns of brain amyloid plaques in mice and that distinct strains of brain Aβ might contribute to the observed clinical heterogeneity among patients with Alzheimer's disease (AD).
↧